Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-04 Option Award | 2024-03-05 5:28 pm | N/A N/A | HENRY SCHEIN INC | HSIC | Tuckson Reed Vaughn Director | 2,604 | $0 | 8,158 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 5:28 pm | N/A N/A | HENRY SCHEIN INC | HSIC | Tuckson Reed Vaughn Director | 495 | $76.88 | 8,158 (Direct) | View |
| 2023-06-26 Equity Swap | 2023-06-26 4:05 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director | 48,639 | $9.1 | 0 (Direct) | View |
| 2023-06-26 Disposition | 2023-06-26 4:05 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director | 596,000 | $0 | 0 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 5:13 pm | N/A 2033-06-08 | Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-04-05 Option Award | 2023-04-07 6:17 pm | N/A 2033-04-05 | CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2023-03-16 Tax Withholding | 2023-03-17 4:27 pm | N/A N/A | HENRY SCHEIN INC | HSIC | Tuckson Reed Vaughn Director | 446 | $78.15 | 6,049 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:11 pm | N/A N/A | HENRY SCHEIN INC | HSIC | Tuckson Reed Vaughn Director | 2,250 | $0 | 6,495 (Direct) | View |
| 2022-12-16 Ownership | 2023-02-14 6:19 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director | 43,785 | $0 | 48,639 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:23 pm | N/A 2032-06-09 | Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-03-16 Option Award | 2022-03-18 8:12 pm | N/A N/A | HENRY SCHEIN INC | HSIC | Tuckson Reed Vaughn Director | 2,028 | $0 | 4,245 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 7:48 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-06-11 Option Award | 2021-06-15 4:39 pm | N/A N/A | HENRY SCHEIN INC | HSIC | Tuckson Reed Vaughn Director | 2,217 | $0 | 2,217 (Direct) | View |
Ownership | 2021-05-19 4:19 pm | N/A N/A | HENRY SCHEIN INC | HSIC | Tuckson Reed Vaughn Director | 0 | $0 | 0 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 6:53 pm | N/A 2031-03-10 | CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-02-19 Option Award | 2021-02-23 7:13 pm | N/A 2031-02-18 | Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director | 45,000 | $0 | 45,000 (Direct) | View |
Ownership | 2021-02-23 7:12 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director | 0 | $0 | 0 (Direct) | View |
| 2020-03-11 Option Award | 2020-03-13 7:46 pm | N/A 2030-03-11 | CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director | 126,000 | $0 | 126,000 (Direct) | View |
| 2019-05-16 Option Award | 2019-05-20 5:26 pm | N/A 2029-05-16 | CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director | 120,000 | $0 | 120,000 (Direct) | View |